Filing Details
- Accession Number:
- 0001185185-16-003479
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-14 18:30:40
- Reporting Period:
- 2016-01-06
- Filing Date:
- 2016-01-14
- Accepted Time:
- 2016-01-14 18:30:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1530766 | Biosig Technologies Inc. | BSGM | Electromedical & Electrotherapeutic Apparatus (3845) | 264333375 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1261041 | Steve Chaussy | C/O Biosig Technologies, Inc. 8441 Wayzata Blvd., Suite 240 Minneapolis MN 55426 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share | Acquisiton | 2016-01-06 | 75,000 | $0.00 | 420,362 | No | 4 | M | Direct | |
| Common Stock, $0.001 Par Value Per Share | Acquisiton | 2016-01-12 | 3,000 | $1.19 | 423,362 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2016-01-06 | 75,000 | $0.00 | 75,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit was settled for one (1) share of common stock.
- Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $1.1895 to $1.19, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc.., any security holder of BioSig Technologies, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- The restricted stock unit award was granted April 30, 2015 and vested in full on January 1, 2016.
Billionaire Hedge Funds
